About Gomti Life Sciences
Gomti Life Sciences is a Healthcare company based in Bengaluru (India) founded in 1977, and was acquired by Advinus Therapeutics in February 2020. It operates as a developer of active pharmaceutical ingredients intermediates. The company has 74 employees. Its chief executive is Mahendra Sharma. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its legal entity in India is Gomti Life Sciences India Private Limited (U24232KA2010PTC055044). Its competitors include Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Founded in 1977, active pharmaceutical ingredients and intermediates are produced by Gomti Life Sciences in the pharmaceutical sector. Operations cover antihypertensives, tocolytics, hematology, and other categories, with manufacturing facilities in Bengaluru, India, certified under ISO 14001 and OHSAS 18001. Contract research, custom synthesis, and analytical services are also provided to support pharmaceutical development.
- Headquarters Bengaluru, India
- Employees 74
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gomtilifesciences.com
- Acquired by Advinus Therapeutics (Feb 2020)
- Legal Name Gomti Life Sciences India Private Limited
- Date of Incorporation 02 Sep, 2010
- Jurisdiction Bangaore, Karnataka, India
- Annual Revenue₹6,460
FY 2023 · -97% YoY
- Net Loss-₹19,570
FY 2023 · -303% margin
- EBITDA-₹26,030
FY 2023 · -403% margin
- Investors
- Employee Count74
- Acquired byAdvinus Therapeutics
(Feb 2020)
Associated legal entities of Gomti Life Sciences
Gomti Life Sciences operates through Gomti Life Sciences India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Gomti Life Sciences India Private Limited CIN U24232KA2010PTC055044 | Active | 02 Sep 2010 | Bangalore, Karnataka | ₹0.0 Cr | 74 | 5 | View details |
Investors in Gomti Life Sciences
Gomti Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Advinus Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Integrated drug discovery and development services are provided. | 2005 | advinus.com | Bengaluru, India |
Investor details for Gomti Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Gomti Life Sciences India Private Limited (Gomti Life Sciences)
Gomti Life Sciences India Private Limited is the primary company behind Gomti Life Sciences. The board of Gomti Life Sciences India Private Limited currently have 5 directors; the longest-serving is Tulsiram Sharma Rameshkumar, appointed in 2010. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tulsiram Sharma Rameshkumar DIN 02840699 | Director | 02 Sep 2010 | 16 yrs 1 mo | Gomti Life Sciences India Private Limited |
| Mahendra Kumar Sharma DIN 00324745 | Managing Director | 02 Sep 2010 | 16 yrs 1 mo | Gomti Life Sciences India Private Limited |
| Manhori Devi DIN 00103537 | Director | 02 Sep 2010 | 16 yrs 1 mo | Gomti Life Sciences India Private Limited |
| Tulsiram Sharma DIN 00103480 | Director | 02 Sep 2010 | 16 yrs 1 mo | Gomti Life Sciences India Private Limited |
| Rajendra Kumar DIN 00103588 | Director | 02 Sep 2010 | 16 yrs 1 mo | Gomti Life Sciences India Private Limited |
People of Gomti Life Sciences
1 people are tracked at Gomti Life Sciences (1 in leadership); the tracked headcount is 74.
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership |
Complete people profiles for Gomti Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Gomti Life Sciences
Figures of Gomti Life Sciences India Private Limited, the primary company behind Gomti Life Sciences, for FY 2023. Revenue was ₹6,460 (-97% year on year). Net loss was -₹19,570 (-303% margin). EBITDA was -₹26,030 (-403% margin). Revenue has grown at a compounded annual rate of -97% over three years and -84% over five years.
- ₹6,460Revenue · FY 2023 · -97% YoY
- -₹19,570Net loss · -303% margin
- -₹26,030EBITDA · -403% margin
- ₹19.17 CrPaid-up capital
- 74Employees (provident fund records)
- -97%Revenue CAGR, 3 years
- -84%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Gomti Life Sciences India Private Limited are on its company page.
Detailed financial statements for Gomti Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Gomti Life Sciences
2 dated milestones of Gomti Life Sciences across 43 years, from founding to its latest funding, stage changes and deals.
- Founded Gomti Life Sciences is founded.
- Exit Acquired by Advinus Therapeutics.
Competitors of Gomti Life Sciences
Gomti Life Sciences has 9 listed competitors in our database, 4 of them funded. They include Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| aciesbio.com | 2006 | Ljubljana, Slovenia | – | – | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | |
| personalchemistry.com | 1998 | Uppsala, Sweden | $50.46M | – | Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. | |
| irbm.com | 2010 | Pomezia, Italy | – | – | Integrated drug discovery and preclinical development services are provided. | |
| nfil.in | 1967 | Mumbai, India | – | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | |
| spirochem.com | 2011 | Zurich, Switzerland | – | – | Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry | |
| medicilon.com | 2004 | Pudong, China | – | – | Integrated drug discovery and preclinical services are provided. | |
| sapalaorganics.com | 2005 | Hyderabad, India | $734,962 | 219 | Research organization specializing in custom synthesis of various organic compounds | |
| liverpoolchirochem.com | 2014 | Liverpool, United Kingdom | $11.07M | 14 | Small organic molecules are supplied for biotech and pharmaceutical R&D. |
Detailed competitors of Gomti Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Gomti Life Sciences (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gomti Life Sciences
Complete news archive for Gomti Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gomti Life Sciences
Gomti Life Sciences was founded in 1977.
Gomti Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Mahendra Sharma is the current CEO of Gomti Life Sciences.
Gomti Life Sciences has 74 employees.
The primary company behind Gomti Life Sciences, Gomti Life Sciences India Private Limited, reported revenue of ₹6,460 for FY 2023, down 97% year on year.
Founded in 1977, active pharmaceutical ingredients and intermediates are produced by Gomti Life Sciences in the pharmaceutical sector. Operations cover antihypertensives, tocolytics, hematology, and other categories, with manufacturing facilities in Bengaluru, India, certified under ISO 14001 and OHSAS 18001. Contract research, custom synthesis, and analytical services are also provided to support pharmaceutical development.
Gomti Life Sciences's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Gomti Life Sciences has 1 investor. Key investors include Advinus Therapeutics.
Gomti Life Sciences operates through Gomti Life Sciences India Private Limited.
Yes. Gomti Life Sciences was acquired by Advinus Therapeutics in February 2020.
The legal entities of Gomti Life Sciences currently have 5 directors, including Tulsiram Sharma Rameshkumar, Mahendra Kumar Sharma, Manhori Devi and others.